Previous Advocacy Updates

The CAP will strongly oppose the MAC First Coast Service Options proposal to adopt an LCD to limit coverage of special IHC stains.

The CAP requested that House lawmakers consider the College’s proposal to establish a regulatory framework for laboratory-developed tests (LDTs).

A House vote on legislation to repeal the Medicare Independent Payment Advisory Board is expected soon after it received committee approval.

Pathologists advocated for strengthening the modernized American Medical Association Code of Medical Ethics during the 2015 AMA Annual Meeting.

The House's 21st Century Cures legislation, which includes reforms to Medicare’s Local Coverage Determination process, received subcommittee approval.

The College advocates for reforms to Medicare’s Local Coverage Determination process in order to increase transparency and boost accountability

The CAP produced short video briefings on Medicare reimbursement changes to immunohistochemistry, in situ hybridization, and prostate biopsy services.

Pathologists will have new opportunities to earn incentives for participating in quality initiatives while never having to face another SGR cut again.

The CAP continues to engage with UnitedHealthcare and oppose the insurer’s Florida laboratory benefit management pilot program that uses BeaconLBS.

The College of American Pathologists (CAP) applauds the House for its passage of HR 2, the Medicare Access and CHIP Reauthorization Act, the bipartisan, bicameral legislation which includes the CAP secured language that gives pathologists much needed flexibility in Medicare's quality initiatives.

The CAP has secured legislative language in the Medicare SGR repeal bill that would give pathologists flexibility in Medicare's quality initiatives.

The CAP and pathologists in Florida strongly oppose UnitedHealthcare’s Beacon pilot program and remain engaged with the insurer over several concerns.

Citing concerns that purported evidence lacks credibility, the CAP continues to vigorously oppose a Medicare LCD on special IHC stains.

The CAP called on the Senate to pass legislation that repeals the Medicare SGR and ensures pathologists can fully participate in a new pay system.

Pathologists’ action leads to more LCD reform support and CMS to release 2017 MIPS scores on July 1.

2018 MIPS reporting resources now available for Pathologists.

CAP leads support of Health Plan Network Adequacy with multiple patient advocacy groups and NJ governor signs balance billing measure into law.

AMA Special Report: CAP Protects Accurate Diagnoses for Patients at 2018 AMA Meeting.

The CAP advocated for the CMS to revise its proposed inpatient payment system regulation that would make hospital standard charges public, increase emphasis on interoperability of HIT, ensure consistent payment rates for CAR-T cell therapy settings, and further extend its “14-day rule” policy to allow laboratories to bill directly for molecular pathology tests. Moreover, CAP members and leaders continue to urge their elected officials to support legislation to increase transparency and accountability in the Medicare Local Coverage Determination (LCD) process.

The CMS sets enforcement discretion period for Laboratory Date of Service Policy and eligible pathologists can request targeted review of their 2019 MIPS Payment Adjustments.